Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GPR84-AS1 (GPR84, ZNF385A, ITGA5 and GTSF1 antisense RNA 1), also known as LINC01154, is a long non-coding RNA (lncRNA) annotated in the human genome. It is named for its genomic arrangement antisense to protein-coding genes in the region (GPR84, ZNF385A, ITGA5, GTSF1), but does not encode a protein and is not itself a protein-coding therapeutic target. There are no published biological functions, molecular disease roles, or clinical uses currently attributed to this lncRNA in the cited databases or literature[1].
Not applicable; no known mechanism, as it is not a receptor or an enzyme.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GPR84, ZNF385A, ITGA5 and GTSF1 antisense RNA 1 (GPR84-AS1).